ORAMED PHARMACEUTICALS INC. Other Current Liabilities
ORAMED PHARMACEUTICALS INC. (ORMP) had Other Current Liabilities of $1.71 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-03-26
- 2025-12-31: Other Liabilities, Current $1.71M.
- 2024-12-31: Other Liabilities, Current $1.37M; Other Liabilities, Current as first filed $59.00K.
- 2024-03-31: Other Liabilities, Current $59.00K.
- 2023-12-31: Other Liabilities, Current $59.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $1.71M 10-K · filed 2026-03-26 | |
| 2024-12-31 | $1.37M 10-K · filed 2026-03-26 | $59.00K 10-K · filed 2025-03-27 |
| 2024-03-31 | $59.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $59.00K 10-K · filed 2024-03-06 | |
| 2023-09-30 | $59.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $96.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $96.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $133.00K 10-K · filed 2023-03-06 | |
| 2022-09-30 | $133.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $169.00K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $169.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $207.00K 10-QT · filed 2022-03-30 | |
| 2021-11-30 | $207.00K 10-Q · filed 2022-01-11 | |
| 2021-08-31 | $243.00 10-K · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |